Zoek expertise

Developing innovative molecular technology to enable novel approaches to study, diagnose and treat immune-system related disease, focus on microbial cell engineering as a basis for the discovery and development of novel immunomodulatory, developing new glyco-analysis tools and animal models to pursue the role of inflammation-induced lymphocyte glycosylation changes in the pathophysiology of inflammatory disease biopharmaceuticals.

Developing new prevention and treatment options to control disease caused by some of the most important human respiratory viruses, including influenza virus, respiratory syncytial virus, and betacoronaviruses.